Page last updated: 2024-09-03

gefitinib and Multiple Myeloma

gefitinib has been researched along with Multiple Myeloma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Abou-Zeid, LA; Ashour, HF; El-Sayed, MA; Selim, KB1
Cao, B; Mao, X; Qiao, C; Wang, Q; Wang, X; Xu, X; Xu, Y; Zeng, K; Zeng, Y; Zhang, J; Zhang, Z1
Chang, H; Chen, G; Chen, Y; Ding, J; Huang, R; Ji, D; Song, B; Yuan, L1
Baudard, M; Cremer, FW; De Vos, J; Fiol, G; Goldschmidt, H; Grau, V; Hose, D; Jourdan, E; Jourdan, M; Klein, B; Mahtouk, K; Moos, M; Moreaux, J; Raab, M; Rème, T; Rossi, JF1

Other Studies

4 other study(ies) available for gefitinib and Multiple Myeloma

ArticleYear
1,2,3-Triazole-Chalcone hybrids: Synthesis, in vitro cytotoxic activity and mechanistic investigation of apoptosis induction in multiple myeloma RPMI-8226.
    European journal of medicinal chemistry, 2020, Mar-01, Volume: 189

    Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle; Cell Proliferation; Chalcones; Humans; Molecular Structure; Multiple Myeloma; Proto-Oncogene Proteins c-bcl-2; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured

2020
Novel conjugates of endoperoxide and 4-anilinoquinazoline induce myeloma cell apoptosis by inhibiting the IGF1-R/AKT/mTOR signaling pathway.
    Bioscience trends, 2020, May-21, Volume: 14, Issue:2

    Topics: Aniline Compounds; Antineoplastic Agents; Apoptosis; Artemisinins; Cell Line, Tumor; Gefitinib; Humans; Multiple Myeloma; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinazolines; Receptor, IGF Type 1; Signal Transduction; TOR Serine-Threonine Kinases

2020
Multiple myeloma acquires resistance to EGFR inhibitor via induction of pentose phosphate pathway.
    Scientific reports, 2015, Apr-20, Volume: 5

    Topics: 6-Aminonicotinamide; Afatinib; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; ErbB Receptors; Gefitinib; Glucose; Humans; Metabolome; Multiple Myeloma; Oxygen; Pentose Phosphate Pathway; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Quinazolines; ras Proteins; Receptor, ErbB-2; RNA, Small Interfering; TOR Serine-Threonine Kinases

2015
Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells.
    Oncogene, 2005, May-12, Volume: 24, Issue:21

    Topics: Amphiregulin; Antineoplastic Agents; Apoptosis; Bone Marrow Cells; Cell Proliferation; EGF Family of Proteins; ErbB Receptors; Gefitinib; Gene Expression Profiling; Glycoproteins; Humans; Intercellular Signaling Peptides and Proteins; Multiple Myeloma; Oligonucleotide Array Sequence Analysis; Plasma Cells; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction

2005